First Comparison of Amulet and Watchman FLX LAA Closure Devices

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Diagnostic and Interventional Cardiology

TCT DAIC

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Structural Heart Occluders

Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

TCT DAIC

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Diagnostic and Interventional Cardiology

Left Atrial Appendage (LAA) Occluders

Left Atrial Appendage (LAA) Occluders

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

Structural Heart Occluders